These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2908581)

  • 1. Leukocyte subsets in the granulomatous response produced after inoculation with Mycobacterium leprae-BCG in lepromatous patients.
    Gross A; Weiss E; Tapia FJ; Aranzazu N; Gallinoto ME; Convit J
    Am J Trop Med Hyg; 1988 May; 38(3):608-12. PubMed ID: 2908581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
    Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
    Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.
    Modlin RL; Hofman FM; Meyer PR; Sharma OP; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Mar; 51(3):430-8. PubMed ID: 6221839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients.
    Ottenhoff TH; Walford C; Nishimura Y; Reddy NB; Sasazuki T
    Eur J Immunol; 1990 Oct; 20(10):2347-50. PubMed ID: 1700754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
    Sasiain MD; de la Barrera S; Valdez R; Balina LM
    Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues.
    Rambukkana A; Burggraaf JD; Faber WR; Harboe M; Teeling P; Krieg S; Das PK
    Infect Immun; 1993 May; 61(5):1835-45. PubMed ID: 7682995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interleukin-2 (IL-2) in the specific unresponsiveness of lepromatous leprosy to Mycobacterium leprae: studies in vitro and in vivo.
    Haregewoin A; Longley J; Bjune G; Mustafa AS; Godal T
    Immunol Lett; 1985; 11(3-4):249-52. PubMed ID: 3936783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies.
    Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U
    Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
    Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR
    Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of defective cytokine activity within lepromatous leprosy lesions.
    Volc-Platzer B; Kremsner P; Stemberger H; Wiedermann G
    Zentralbl Bakteriol; 1990 Apr; 272(4):458-66. PubMed ID: 1972881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism of human T cell suppression.
    Salgame P; Modlin R; Bloom BR
    Int Immunol; 1989; 1(2):121-9. PubMed ID: 2535060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged dapsone chemotherapy.
    Gill HK; Ridley DS; Ganesan J; Mustafa AS; Rees RJ; Godal T
    Lepr Rev; 1990 Mar; 61(1):25-31. PubMed ID: 2181222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
    Garraud O; Ribierre O; Bach MA
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients.
    Corbeau P; Desforges S; Bach MA
    Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800
    [No Abstract]   [Full Text] [Related]  

  • 20. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF.
    Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Michel JC; Bach MA
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.